Contribution of thromboxane A2 in rat common carotid artery response to serotonin

Scientia Pharmaceutica

Volumn 78, Issue 3, 2010, Pages 435-443

  Radenković, Miroslav ^a   Stojanović, Marko ^a   Topalović, Mirko ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Common carotid artery; Endothelium; Serotonin; Thromboxane A2

Indexed keywords

BICARBONATE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; INDOMETACIN; KETANSERIN; NIFEDIPINE; OZAGREL; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SEROTONIN; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; THROMBOXANE A2; THROMBOXANE SYNTHASE INHIBITOR;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; COMMON CAROTID ARTERY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESPONSE; ENDOTHELIUM; MALE; MUSCLE CELL; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; VASCULAR RING; VASCULARIZATION; VASOCONSTRICTION;

EID: 77957354360     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1004-04     Document Type: Article

References (22)

1. Wallerstedt SM, Törnebrandt K Bodelsson M. Characterisation of contractile 5-HT receptors in isolated human omental arteries: presence of 5-HT1 and 5-HT2 receptors. Pharmacol Toxicol. 1996; 78: 50-54. doi:10.1111/j.1600-0773.1996.tb00179.x
2. De Vries P, Villalón CM, Heiligers JPC, Saxena PR. Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses, involvement of 5-HT1B/1D and novel receptors. Brit J Pharmacol. 1998; 123: 1561-1570. doi:10.1038/sj.bjp.0701770
3. Verheggen R, Hundeshagen AG, Brown AM, Schindler M, Kaumann AJ. 5-HT1B receptor-mediated contractions in human temporal artery: evidence from selective antagonists and 5-HT receptor mRNA expression. Brit J Pharmacol. 1998; 124: 1345-1354. doi:10.1038/sj.bjp.0701929
4. Lovren F, Li X, Lytton J, Triggle C. Functional characterization and m-RNA expression of 5-HT receptors mediating contraction in human umbilical artery. Br J Pharmacol. 1999; 127: 1247-1255. doi:10.1038/sj.bjp.0702647
5. Van Nueten JM, Janssens WJ. Augmentation of vasoconstrictor responses to serotonin by acute and chronic factors: inhibition by ketanserin. J Hypertens Suppl. 1986; 4: S55-S59. PMid:2939213
6. Weiner CP, Chestnut DH, Herrig JE, Hdez M. The interaction of serotonin, norepinephrine, epinephrine, and angiotensin II during pregnancy. Clin Exp Hypertens Pregnancy. 1990; B9: 211-224. doi:10.3109/10641959009072255
7. Whiting MV, Cambridge D. Canine renovascular response to sumatriptan and 5-carboxyamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxide. Brit J Pharmacol. 1995; 114: 969-974. PMid:7780652
8. Morecroft I, MacLean MR. 5-Hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries. Brit J Pharmacol. 1998; 125: 69-78. doi:10.1038/sj.bjp.0702055
9. Pagniez F, Valentin JP, Vieu S, Colpaert FC, John GW. Pharmacological analysis of the haemodynamic effect of 5-HT1B/D receptor agonists in the normotensive rat. Brit J Pharmacol. 1998; 123: 205-214. doi:10.1038/sj.bjp.0701593
10. Descombes JJ, Devys M, Laubie M and Verbeuren TJ. Endothelial thromboxane production plays a role in the contraction caused by 5-hydroxytryptamine in rat basilar arteries. Eur J Pharmacol. 1993; 243: 193-199. doi:10.1016/0014-2999(93)90380-Z
11. Howarth SR, Vallance P, Wilson CA. Role of thromboxane A2 in the vasoconstrictor response to endothelin-1, angiotensin II and 5-hydroxytryptamine in human placental vessels. Placenta. 1995; 16: 679-689. doi:10.1016/0143-4004(95)90012-8
12. Thorin E, Thanh-Dung N, Bouthillier A. Control of vascular tone by endogenous endothelin-1 in human pial arteries. Stroke. 1998; 29: 175-180. PMid:9445348
13. De Meyer GR, Bult H, Ustünes L, Kockx M, Jordaens FH, Zonnekeyn LL, Herman AG. Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery. Br J Pharmacol. 1994; 112: 471-476. PMid:7521257
14. Takiuchi S, Rakugi H, Fujii H, Kamide K, Horio T, Nakatani S, Kawano Y, Higaki J, Ogihara T. Carotid intima-media thickness is correlated with impairment of coronary flow reserve in hypertensive patients without coronary artery disease. Hypertens Res. 2003; 26: 945-951. doi:10.1291/hypres.26.945
15. Hallerstam S, Larsson PT, Zuber E, Rosfors S. Carotid atherosclerosis is correlated with extent and severity of coronary artery disease evaluated by myocardial perfusion scintigraphy. Angiology. 2004; 55: 281-288. doi:10.1177/000331970405500307
16. Miranda FJ, Alabadí JA, Lloréns S, Ruiz de Apodaca RF, Centeno JM, Alborch E. Diabetes-induced changes in endothelial mechanisms implicated in rabbit carotid arterial response to 5-hydroxytryptamine. Eur J Pharmacol. 2000; 401: 397-402. doi:10.1016/S0014-2999(00)00469-6
17. Lüscher TF, Diederich D, Weber E, Vanhoutte PM, Bühler FR. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension. 1988; 11: 573-578. PMid:3260580
18. Kanagy NL, Mecca TE, Webb RC. Arachidonate metabolites and serotonin contraction of femoral arteries from DOCA-salt hypertensive rats. Blood Press. 1996; 5: 113-120. doi:10.3109/08037059609062117
19. Tsurumaki T, Nagai S, Bo X, Toyosato A, Higuchi H. Potentiation by neuropeptide Y of 5HT2A receptor-mediated contraction in porcine coronary artery. Eur J Pharmacol. 2006; 544: 111-117. doi:10.1016/j.ejphar.2006.06.036
20. Radenković M, Radunović N, Momčilov P, Grbović L. Altered response of human umbilical artery to 5-HT in gestational diabetic pregnancy. Pharmacol Rep. 2009; 61: 520-528. PMid:19605952
21. Yildiz O, Tuncer M. Comparison of the effect of endothelium on the responses to sumatriptan in rabbit isolated iliac, mesenteric and carotid arteries. Arch Int Pharmacodyn Ther. 1994; 328: 200-212. PMid:7710305
22. Fujiwara T, Chiba S. Augmented responses to 5-HT2-receptor-mediated vasoconstrictions in atherosclerotic rabbit common carotid arteries. J Cardiovasc Pharmacol. 1995; 26: 503-510. doi:10.1097/00005344-199509000-00023